Canton Strategic (CNTN) vs NRX Pharmaceuticals (NRXP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
NRX Pharmaceuticals (NRXP) has outperformed Canton Strategic (CNTN) over the past year, gaining 0.9% versus a loss of 50.6%. Canton Strategic is the larger company by market cap ($98.8 million vs $95.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTN | NRXP |
|---|---|---|
| Share price | $1.21 | $2.15 |
| Market cap | $98.78M | $95.31M |
| 1-day change | -1.63% | -15.69% |
| YTD return | -60.07% | -20.66% |
| 1-year return | -50.61% | +0.94% |
| 5-year return | — | -96.81% |
| P/E ratio (TTM) | 20.17 | — |
| EPS (TTM) | $0.06 | $-0.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.23M |
| Net income (latest FY) | $-35.92M | $-28.62M |
| Gross margin | — | 58.78% |
| Operating margin | — | -1324.41% |
| Net margin | — | -2336.49% |
| 52-week high | $5.83 | $5.06 |
| 52-week low | $1.19 | $1.62 |
| Distance from 52-week high | -79.25% | -57.47% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +1702.33% |
| Average volume | 763.63K | 1.07M |
| Shares outstanding | 81.64M | 44.33M |
| Employees | 12 | 29 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NRXP has outperformed CNTN by 51.6 percentage points over the past year.
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About NRX Pharmaceuticals
NRXP stock →NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees
CNTN vs NRXP FAQ
Which is bigger, Canton Strategic or NRX Pharmaceuticals?
Canton Strategic (CNTN) is larger, with a market capitalization of $98.78M compared with $95.31M for NRX Pharmaceuticals (NRXP).
Which stock has performed better over the past year, CNTN or NRXP?
NRXP returned +0.94% over the past 12 months, compared with -50.61% for CNTN (price return, excluding dividends). Past performance does not predict future results.
Are Canton Strategic and NRX Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.